M

MDGL

MDGL

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio22% buys
BearishBullish

Insider Buys

2

$61.92M

Insider Sales

60

$225.82M

Total Volume

$287.74M

100 transactions

Net Activity

$163.90M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
30Confidence

Sentiment Rating

Moderate Distribution

CEO Conviction Index

Liquidating / Profit Taking

Key Drivers

  • •Heavy distribution: sales represent 78% of total transaction value.
  • •CEO selling activity detected. Often driven by option expiration or diversification plans.
  • •Ultra-high accumulation: total purchase value exceeds $10M.
  • •Significant liquidation: total sale value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Sector & Industry
Unknown Comparison
Industry Buy Conviction20%
MDGL Buy Conviction22%
Industry Rank#0 of 270
Volume Contribution28.5%
Total Industry Activity$1.01B

MDGL has an insider buy conviction of 22%, compared to the Unknown sector buy average of 20%.

Top Insiders
Most active traders
M
1

Multiple Insiders

S - Sale Insiders

0 buys38 sells

$189.08B total

F
2

Friedman Paul A

Dir

0 buys7 sells

$101.80M total

B
3

Baker Bros. Advisors LP

Dir

2 buys0 sells

$61.92M total

T
4

Taub Rebecca

Dir

0 buys11 sells

$49.49M total

B
5

Bate Kenneth

Dir

0 buys3 sells

$18.81M total

Insider Trading Summary
Automated trend commentary

Over the last 90 days, corporate insiders at MDGL (MDGL) engaged in a total of 100 transactions reported via SEC Form 4 filings. Among these, 2 were open-market purchases and 60 were sales. The total volume of insider trading reached $287.74M.

The net insider activity for MDGL shows a net selling bias of $163.90M. This activity represents a 22% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 1.95M shares valued at $189.08B on Aug 18, 2025.

Trading History
MDGL insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Sep 9, 2026

1 months ago

Sibold William John

Pres, CEO

CEO
Sell11.6K$538.65$6.24M

Sep 9, 2026

1 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell197.7K$-11583.00$0

Aug 17, 2026

2 months ago

Kelley Shannon T

GC

General Counsel
Sell664$514.97$342K

Aug 17, 2026

2 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell11.5K$-664.00$0

Jul 20, 2026

3 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell209.3K$-2500.00$0

Jul 20, 2026

3 months ago

Sibold William John

Pres, CEO

CEO
Sell2.5K$547.30$1.37M

Jun 1, 2026

4 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell10.0K$-1042.00$0

Jun 1, 2026

4 months ago

Soergel David

Chief Medical Officer

C-Level
Sell1.0K$495.74$517K

May 22, 2026

5 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell22.0K$-5682.00$0

May 22, 2026

5 months ago

Levy Richard S

Dir

Director
Sell5.7K$515.44$2.93M

May 18, 2026

5 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell11.1K$-844.00$0

May 18, 2026

5 months ago

Soergel David

Chief Medical Officer

C-Level
Sell844$515.90$435K

Mar 6, 2026

7 months ago

Huntsman Carole

Chief Commercial Officer

C-Level
Sell419$431.94$181K

Mar 6, 2026

7 months ago

Taub Rebecca

Dir

Director
Sell491$431.94$212K

Mar 6, 2026

7 months ago

Dier Mardi

EVP, CFO

CFO
Sell2.0K$430.87$854K

Mar 6, 2026

7 months ago

Kelley Shannon T

GC

General Counsel
Sell360$431.94$155K

Mar 6, 2026

7 months ago

Sibold William John

Pres, CEO

CEO
Sell1.7K$431.94$718K

Mar 6, 2026

7 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell12.5K$-1982.00$0

Mar 2, 2026

8 months ago

Dier Mardi

EVP, CFO

CFO
Sell1.2K$427.21$505K

Mar 2, 2026

8 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell9.3K$-1183.00$0

Jan 26, 2026

9 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell9.1K$-910.00$0

Jan 26, 2026

9 months ago

Taub Rebecca

Dir

Director
Sell647$492.42$319K

Jan 26, 2026

9 months ago

Sibold William John

Pres, CEO

CEO
Sell1.6K$492.42$777K

Jan 26, 2026

9 months ago

Huntsman Carole

Chief Commercial Officer

C-Level
Sell910$493.78$449K

Jan 20, 2026

9 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell8.5K$-692.00$0

Jan 20, 2026

9 months ago

Taub Rebecca

Dir

Director
Sell2.2K$490.77$1.10M

Jan 20, 2026

9 months ago

Kelley Shannon T

GC

General Counsel
Sell692$497.36$344K

Jan 9, 2026

9 months ago

Friedman Paul A

Dir

Director
Sell280$551.24$154K

Jan 9, 2026

9 months ago

Friedman Paul A

Dir

Director
Sell24.5K$522.39$12.81M

Jan 9, 2026

9 months ago

Taub Rebecca

Dir

Director
Sell240$550.33$132K

Jan 9, 2026

9 months ago

Taub Rebecca

Dir

Director
Sell18.4K$522.40$9.62M

Jan 9, 2026

9 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell842.7K$-280.00$0

Dec 10, 2025

10 months ago

Taub Rebecca

Dir

Director
Sell18.6K$552.15$10.30M

Dec 10, 2025

10 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell842.7K$-24800.00$0

Dec 10, 2025

10 months ago

Friedman Paul A

Dir

Director
Sell24.8K$552.18$13.69M

Dec 4, 2025

10 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell150.1K$-2400.00$0

Dec 4, 2025

10 months ago

Sibold William John

Pres, CEO

CEO
Sell2.4K$575.34$1.38M

Dec 2, 2025

11 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell10.4K$-4173.00$0

Dec 2, 2025

11 months ago

Dier Mardi

EVP, CFO

CFO
Sell4.2K$578.34$2.41M

Nov 21, 2025

11 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell10.0K$-1958.00$0

Nov 21, 2025

11 months ago

Huntsman Carole

Chief Commercial Officer

C-Level
Sell2.0K$553.11$1.08M

Nov 13, 2025

11 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell21.2K$-8500.00$0

Nov 13, 2025

11 months ago

Levy Richard S

Dir

Director
Sell8.5K$520.96$4.43M

Nov 5, 2025

11 months ago

Bate Kenneth

Dir

Director
Sell16.6K$484.31$8.03M

Nov 5, 2025

11 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell2.6K$-16575.00$0

Sep 9, 2025

13 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell102.5K$-7279.00$0

Sep 9, 2025

13 months ago

Sibold William John

Pres, CEO

CEO
Sell7.3K$445.63$3.24M

Aug 21, 2025

14 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell109.8K$-7616.00$0

Aug 21, 2025

14 months ago

Sibold William John

Pres, CEO

CEO
Sell7.6K$400.18$3.05M

Aug 18, 2025

14 months ago

Baker Bros. Advisors LP

Dir

Director
Buy68.6K$364.04$24.98M

Aug 18, 2025

14 months ago

Baker Bros. Advisors LP

Dir

Director
Buy97.1K$380.58$36.94M

Aug 18, 2025

14 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell1.95M$97065.00$189.08B

Aug 18, 2025

14 months ago

Kelley Shannon T

GC

General Counsel
Sell1.3K$367.81$480K

Aug 15, 2025

14 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell2.6K$-10000.00$0

Aug 15, 2025

14 months ago

Bate Kenneth

Dir

Director
Sell10.0K$365.20$3.65M

Aug 13, 2025

14 months ago

Friedman Paul A

Dir

Director
Sell129.2K$370.24$47.83M

Aug 11, 2025

14 months ago

Friedman Paul A

Dir

Director
Sell46.8K$355.31$16.63M

Aug 11, 2025

14 months ago

Taub Rebecca

Dir

Director
Sell46.5K$355.32$16.51M

Aug 11, 2025

14 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell842.7K$-46808.00$0

Aug 13, 2025

14 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell842.7K$-129172.00$0

Jul 18, 2025

15 months ago

Taub Rebecca

Dir

Director
Sell1.0K$350.01$350K

Jul 18, 2025

15 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell1.12M$-1000.00$0

Jul 18, 2025

15 months ago

Friedman Paul A

Dir

Director
Sell1.4K$350.03$490K

Jul 16, 2025

15 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell842.7K$-28876.00$0

Jul 16, 2025

15 months ago

Taub Rebecca

Dir

Director
Sell29.1K$353.19$10.28M

Jul 16, 2025

15 months ago

Friedman Paul A

Dir

Director
Sell28.9K$353.19$10.20M

Mar 12, 2025

19 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell383.5K$-15470.00$0

Mar 12, 2025

19 months ago

Craves Fred B

Dir

Director
Sell15.5K$328.54$5.08M

Mar 10, 2025

19 months ago

Dier Mardi

SVP, CFO

CFO
Sell258$323.04$83K

Mar 10, 2025

19 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell10.4K$-258.00$0

Mar 5, 2025

20 months ago

Waltermire Robert E.

SVP, Chief Pharma Dev.

SVP
Sell14.1K$341.32$4.82M

Mar 5, 2025

20 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell5.8K$-14113.00$0

Mar 3, 2025

20 months ago

Kelley Shannon T

GC

General Counsel
Sell415$335.00$139K

Mar 3, 2025

20 months ago

Dier Mardi

SVP, CFO

CFO
Sell2.0K$324.96$637K

Mar 3, 2025

20 months ago

Huntsman Carole

Chief Commercial Officer

C-Level
Sell1.8K$325.98$598K

Mar 3, 2025

20 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell7.3K$-415.00$0

Feb 28, 2025

20 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell3.7K$-1227.00$0

Feb 28, 2025

20 months ago

Waltermire Robert E.

SVP, Chief Pharma Dev.

SVP
Sell1.2K$341.07$418K

Feb 27, 2025

20 months ago

Bate Kenneth

Dir

Director
Sell20.0K$356.44$7.13M

Feb 27, 2025

20 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell1.9K$-15470.00$0

Feb 27, 2025

20 months ago

Daly James M

Dir

Director
Sell15.5K$347.46$5.38M

Jan 24, 2025

21 months ago

Taub Rebecca

Pres, R, D,, CMO

President
Sell648$335.24$217K

Jan 24, 2025

21 months ago

Sibold William John

Pres, CEO

CEO
Sell1.6K$335.24$531K

Jan 24, 2025

21 months ago

Huntsman Carole

Chief Commercial Officer

C-Level
Sell347$335.24$116K

Jan 24, 2025

21 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell10.4K$-347.00$0

Jan 24, 2025

21 months ago

Waltermire Robert E.

SVP, Chief Pharma Dev.

SVP
Sell103$335.24$35K

Jan 17, 2025

21 months ago

Waltermire Robert E.

SVP, Chief Pharma Dev.

SVP
Sell442$273.41$121K

Jan 17, 2025

21 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell7.7K$-277.00$0

Jan 17, 2025

21 months ago

Kelley Shannon T

GC

General Counsel
Sell277$273.41$76K

Jan 17, 2025

21 months ago

Taub Rebecca

Pres, R, D,, CMO

President
Sell1.7K$273.41$462K

Dec 3, 2024

23 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell383.5K$-3600.00$0

Dec 3, 2024

23 months ago

Craves Fred B

Dir

Director
Sell3.6K$315.31$1.14M

Nov 25, 2024

23 months ago

Craves Fred B

Dir

Director
Sell3.4K$350.30$1.19M

Nov 25, 2024

23 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell387.1K$-3400.00$0

Nov 21, 2024

23 months ago

Huntsman Carole

Chief Commercial Officer

C-Level
Sell688$316.92$218K

Nov 21, 2024

23 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell10.8K$-688.00$0

Nov 7, 2024

24 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell11.0K$-5000.00$0

Nov 7, 2024

24 months ago

Levy Richard S

Dir

Director
Sell5.0K$350.00$1.75M

Nov 1, 2024

24 months ago

Levy Richard S

Dir

Director
Sell5.0K$300.94$1.50M

Nov 1, 2024

24 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell11.0K$-5000.00$0

FAQs About MDGL Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for MDGL.

Based on SEC Form 4 disclosures, the Insider Confidence Score for MDGL is currently 30/100, which reflects a moderate distribution bias. This calculation accounts for a total of 2 purchases and 60 sales by company executives over the last 90 days.

The CEO Conviction Index for MDGL is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.